Keratins are a family of IF proteins typically found in epithelial cells. In cancer, changes in keratin expression patterns can influence tumor behavior and patient prognosis. For example, a shift from keratin 18 to keratin 19 expression in some carcinomas is associated with increased malignancy and poorer outcomes. Understanding these alterations can aid in the classification of tumor types and the development of targeted therapies.